![]() The study was conducted in accordance with the principles of the Helsinki Declaration, and approved by the Ministry of Health of the Czech Republic and by the 1st Faculty of Medicine, Charles University. The present study aims to assess the safety and efficacy of a shockwave device, the Piezowave² device of Richard Wolf GmbH, which offers substantially superior treatment parameters and organ coverage using a new Linear Shockwave Tissue Coverage LSTC-ED ® technique. Current methods for treating vasculogenic ED aim to reduce symptoms rather than reverse the cause of the disorder, which in most cases is due to disorders affecting arterial inflow, so the use of shockwaves to treat ED has been evaluated using a modified orthopedic device. It has been demonstrated that shockwaves can improve intrinsic angiogenic activity when used to treat ischemic heart disease. Vascular diseases such as diabetes mellitus or atherosclerotic vascular occlusive disease are present in up to 60% of ED patients. Alterations in the vascular hemodynamics are believed to be the most common cause of organic erectile dysfunction. The association between vascular disease and erectile dysfunction has been recognized and well documented. Received 20 February 2016 accepted 4 April 2016 published 7 April 2016Įrectile dysfunction (ED) is defined as inability to achieve or maintain erection adequate for sexual intercourse. Proved to be suitable and effective to treat erectile dysfunction. The Piezowave 2 device and the LSTC-ED ® technique No significant adverse effects were observed during Improvement based on IIEF score, and 8 reported an improvement based on theirĪnswers to the TSQ. In the placebo group of 50 patients only 5 patients showed an ![]() Questionnaire (answers 1 to 3 of the TSQ), treatment was successful in 77.3% of According to the IIEF-5 scale, treatment was successful Patients in the treatment group increased from 14.4 at baseline to 18.6 at 1 Placebo the outcomes of both groups were compared. The study also included a group of 50 patients treated by Patients were additionally questioned using our own Treatment Satisfaction Was evaluated using the modified IIEF-5 (International Index of Erectileįunction) scale at the beginning of treatment and at 1 month post treatment ![]() A total of 75 patients were treated using the Piezowave 2 device and the LSTC-ED ® technique. With vasculogenic ED using a novel linear shockwave tissue coverage LSTC-ED ® technique. Shockwave device (Richard Wolf/ELvationPiezowave 2 ) to treat patients Present study aimed to demonstrate the efficacy of a linear focused piezoelectric The method has beenĮvaluated and is used to treat vasculogenic erectile dysfunction (ED). (LiSW) treatment is known to improve revascularization. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |